AI assistant
Spineway Report Publication Announcement 2021
1683_iss_2021-01-08_d3c57257-7bbf-44af-9a16-0ef98f9c5319.pdf
Report Publication Announcement
Open in viewerOpens in your device viewer
Spineway 2021 Financial Calendar
SPINEWAY (ISIN : FR0011398874 – ALSPW), specialized in the treatment of severe disorders of the spine, announced today its 2021 financial calendar* :
| January 14, 2021: | Publication of 2020 turnover |
|---|---|
| February 26, 2021: | 2020 annual results |
| March 2, 2021 : |
Annual results meeting |
| April 15, 2021: | Publication of Q1 2021 turnover |
| July 13, 2021: | Publication of half-year 2021 turnover |
| September 6, 2021: | First half-year results |
| September 8, 2021: | Half-year results meeting |
| October 14, 2021: | Publication of Q3 2021 turnover |
* This calendar is indicative. Spineway reserves its rights to modify the above dates if it seems it necessary. Results will be released after the market closes (Euronext, Paris).
SPINEWAY IS ELIGIBLE FOR THE PEA-PME (EQUITY SAVINGS PLANS FOR SMES) Find out all about Spineway at www.spineway.com
This press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail.
Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.
Spineway has an international network of over 50 independent distributors and 90% of its revenue comes from exports. Spineway, which is eligible for investment through FCPIs (French unit trusts specializing in innovation), has received the OSEO Excellence award since 2011 and has won the Deloitte Fast 50 award (2011). Rhône Alpes INPI Patent Innovation award (2013) – INPI Talent award (2015). ISIN: FR0011398874 - ALSPW
Contacts :
Shareholder-services line Available Tuesday through Thursday (10 a.m. – 12 p.m. ) +33 (0)811 045 555
Solène Kennis [email protected]